Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: COG ADVL1211 Principal Investigator: Hayashi, Robert
Title: A Phase I Study of XL184 (Cabozantinib, IND# 116059) in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)